{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:09:34Z","timestamp":1790352574408,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T00:00:00Z","timestamp":1565740800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T00:00:00Z","timestamp":1565740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Institute of Health","award":["DK-61578"],"award-info":[{"award-number":["DK-61578"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s11010-019-03602-y","type":"journal-article","created":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T17:02:40Z","timestamp":1565802160000},"page":"195-204","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Role of angiotensin type 2 receptor in improving lipid metabolism and preventing adiposity"],"prefix":"10.1007","volume":"461","author":[{"given":"Sourashish","family":"Nag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanket","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailaja","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6353-2317","authenticated-orcid":false,"given":"Tahir","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,14]]},"reference":[{"key":"3602_CR1","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1161\/01.CIR.67.5.968","volume":"67","author":"HB Hubert","year":"1983","unstructured":"Hubert HB, Feinleib M, McNamara PM, Castelli WP (1983) Obesity as an independent risk factor for cardiovascular disease\u2014a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67:968\u2013977","journal-title":"Circulation"},{"key":"3602_CR2","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.7326\/0003-4819-103-6-1010","volume":"103","author":"EL Barrett-Connor","year":"1985","unstructured":"Barrett-Connor EL (1985) Obesity, atherosclerosis, and coronary artery disease. Ann Intern Med 103:1010\u20131019","journal-title":"Ann Intern Med"},{"key":"3602_CR3","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0026-0495(90)90002-T","volume":"39","author":"RC Bonadonna","year":"1990","unstructured":"Bonadonna RC, Leif G, Kraemer N, Ferrannini E, Del Prato S, DeFronzo RA (1990) Obesity and insulin resistance in humans: a dose-response study. Metabolism 39:452\u2013459","journal-title":"Metabolism"},{"key":"3602_CR4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1042\/CS20090395","volume":"118","author":"AA Elmarakby","year":"2010","unstructured":"Elmarakby AA, Imig JD (2010) Obesity is the major contributor to vascular dysfunction and inflammation in high-fat diet hypertensive rats. Clin Sci 118:291\u2013301","journal-title":"Clin Sci"},{"key":"3602_CR5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/clpt.2009.311","volume":"87","author":"P Mathieu","year":"2010","unstructured":"Mathieu P, Lemieux I, Despres JP (2010) Obesity, inflammation, and cardiovascular risk. Clin Pharmacol Ther 87:407\u2013416","journal-title":"Clin Pharmacol Ther"},{"key":"3602_CR6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1751-7176.2008.00059.x","volume":"11","author":"GJ Fodor","year":"2009","unstructured":"Fodor GJ, McInnis NH, Helis E, Turton P, Leenen FH (2009) Lifestyle changes and blood pressure control: a community-based cross-sectional survey (2006 Ontario Survey on the Prevalence and Control of Hypertension). J Clin Hypertens 11:31\u201335","journal-title":"J Clin Hypertens"},{"key":"3602_CR7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/1756-0500-6-213","volume":"6","author":"SP Jansson","year":"2013","unstructured":"Jansson SP, Engfeldt P, Magnuson A, Lohse G, Liljegren G (2013) Interventions for lifestyle changes to promote weight reduction, a randomized controlled trial in primary health care. BMC Res Notes 6:213","journal-title":"BMC Res Notes"},{"key":"3602_CR8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1124\/mi.8.2.6","volume":"8","author":"SR Bloom","year":"2008","unstructured":"Bloom SR, Kuhajda FP, Laher I, Pi-Sunyer X, Ronnett GV, Tan TM, Weigle DS (2008) The obesity epidemic\u2014pharmacological challenges. Mol Interv 8:82\u201398","journal-title":"Mol Interv"},{"key":"3602_CR9","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1242\/dmm.009621","volume":"5","author":"RJ Rodgers","year":"2012","unstructured":"Rodgers RJ, Tschop MH, Wilding JP (2012) Anti-obesity drugs: past, present and future. Dis Model Mech 5:621\u2013626","journal-title":"Dis Model Mech"},{"key":"3602_CR10","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1152\/physrev.1998.78.3.783","volume":"78","author":"FM Greqoir","year":"1998","unstructured":"Greqoir FM, Smas CM, Sul HS (1998) Understanding adipocyte differentiation. Physiol Rev 78:783\u2013809","journal-title":"Physiol Rev"},{"key":"3602_CR11","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1128\/MCB.26.9.3455-3467.2006","volume":"26","author":"Q Wu","year":"2006","unstructured":"Wu Q, Ortegon AM, Tsang B, Doege H, Feingold KR, Stahl A (2006) FATP1 is an insulin-sensitive fatty acid transporter involved in diet-induced obesity. Mol Cell Biol 26:3455\u20133467","journal-title":"Mol Cell Biol"},{"key":"3602_CR12","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1172\/JCI200418917","volume":"113","author":"JK Kim","year":"2004","unstructured":"Kim JK, Gimeno RE, Higashimori T, Kim H-J, Choi H, Punreddy S, Mozell RL, Tan G, Stricker-Krongrad A, Hirsch DJ, Fillmore JJ, Liu Z-X, Dong J, Cline G, Stahl A, Lodish HF, Shulman GI (2004) Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle. J Clin Invest 113:756\u2013763","journal-title":"J Clin Invest"},{"key":"3602_CR13","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1007\/s00125-004-1417-4","volume":"47","author":"K Gertow","year":"2004","unstructured":"Gertow K, Pietilainen KH, Yki-Jarvinen H, Kaprio J, Rissanen A, Eriksson P, Hamsten A, Fisher RM (2004) Expression of fatty-acid-handling proteins in human adipose tissue in relation to obesity and insulin resistance. Diabetologia 47:1118\u20131125","journal-title":"Diabetologia"},{"key":"3602_CR14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ki.2010.391","volume":"79","author":"L Yvan-Charvet","year":"2011","unstructured":"Yvan-Charvet L, Quignard-Boulange A (2011) Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity. Kidney Int 79:162\u2013168","journal-title":"Kidney Int"},{"key":"3602_CR15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1467-789X.2011.00942.x","volume":"13","author":"NS Kalupahana","year":"2012","unstructured":"Kalupahana NS, Moustaid-Moussa N (2012) The renin-angiotensin system: a link between obesity, inflammation and insulin resistance. Obes Rev 13:136\u2013149","journal-title":"Obes Rev"},{"key":"3602_CR16","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.metabol.2015.01.019","volume":"64","author":"S Nag","year":"2015","unstructured":"Nag S, Khan MA, Samuel P, Ali Q, Hussain T (2015) Chronic angiotensin AT2R activation prevents high-fat diet-induced adiposity and obesity in female mice independent of estrogen. Metabolism 64:814\u2013825","journal-title":"Metabolism"},{"key":"3602_CR17","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/01.HYP.0000151622.47814.6f","volume":"45","author":"AC Hakam","year":"2005","unstructured":"Hakam AC, Hussain T (2005) Renal angiotensin II type-2 receptors are upregulated and mediate the candesartan-induced natriuresis\/diuresis in obese Zucker rats. Hypertens 45:270\u2013275","journal-title":"Hypertens"},{"key":"3602_CR18","doi-asserted-by":"crossref","first-page":"543062","DOI":"10.1155\/2012\/543062","volume":"2012","author":"ES Jones","year":"2012","unstructured":"Jones ES, Black MJ, Widdop RE (2012) Influence of angiotensin II subtype 2 receptor (AT(2)R) antagonist, PD123319, on cardiovascular remodelling of aged spontaneously hypertensive rats during chronic angiotensin II subtype 1 receptor (AT(1)R) blockade. Int J Hypertens 2012:543062","journal-title":"Int J Hypertens"},{"key":"3602_CR19","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1210\/en.2012-1352","volume":"153","author":"K Putnam","year":"2012","unstructured":"Putnam K, Batifoulier-Yiannikouris F, Bharadwaj KG, Lewis E, Karounos M, Daugherty A, Cassis LA (2012) Deficiency of angiotensin type 1a receptors in adipocytes reduces differentiation and promotes hypertrophy of adipocytes in lean mice. Endocrinology 153:4677\u20134686","journal-title":"Endocrinology"},{"key":"3602_CR20","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2337\/diabetes.54.4.991","volume":"54","author":"L Yvan-Charvet","year":"2005","unstructured":"Yvan-Charvet L, Even P, Bloch-Faure M, Guerre-Millo M, Moustaid-Moussa N, Ferre P, Quignard-Boulange A (2005) Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance. Diabetes 54:991\u2013999","journal-title":"Diabetes"},{"key":"3602_CR21","doi-asserted-by":"crossref","first-page":"e48425","DOI":"10.1371\/journal.pone.0048425","volume":"8","author":"P Samuel","year":"2013","unstructured":"Samuel P, Khan MA, Nag S, Inagami T, Hussain T (2013) Angiotensin AT(2) receptor contributes towards gender bias in weight gain. PLoS ONE 8:e48425","journal-title":"PLoS ONE"},{"key":"3602_CR22","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/ajh.2009.85","volume":"22","author":"M Iwai","year":"2009","unstructured":"Iwai M, Tomono Y, Inaba S, Kanno H, Senba I, Mogi M, Horiuchi M (2009) AT2 receptor deficiency attenuates adipocyte differentiation and decreases adipocyte number in atherosclerotic mice. Am J Hypertens 22:784\u2013791","journal-title":"Am J Hypertens"},{"key":"3602_CR23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.nbd.2012.11.008","volume":"51","author":"P Namsolleck","year":"2013","unstructured":"Namsolleck P, Boato F, Schwengel K, Paulis L, Matho KS, Geurts N, Thone-Reineke C, Lucht K, Seidel K, Hallberg A, Dahlof B, Unger T, Hendrix S, Steckelings UM (2013) AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression. Neurobiol Dis 51:177\u2013191","journal-title":"Neurobiol Dis"},{"key":"3602_CR24","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1161\/HYPERTENSIONAHA.110.164202","volume":"57","author":"LC Matavelli","year":"2011","unstructured":"Matavelli LC, Huang J, Siragy HM (2011) Angiotensin AT(2) receptor stimulation inhibits early renal inflammation in renovascular hypertension. Hypertens 57:308\u2013313","journal-title":"Hypertens"},{"key":"3602_CR25","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00125-016-3933-4","volume":"59","author":"V Pellegrinelli","year":"2016","unstructured":"Pellegrinelli V, Carobbio S, Vidal-Puig A (2016) Adipose tissue plasticity: how fat depots respond differently to pathophysiological cues. Diabetologia 59:1075\u20131088","journal-title":"Diabetologia"},{"key":"3602_CR26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0092-8674(94)90252-6","volume":"79","author":"JE Schaffer","year":"1994","unstructured":"Schaffer JE, Lodisht HF (1994) Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell 79:427\u2013436","journal-title":"Cell"},{"key":"3602_CR27","doi-asserted-by":"crossref","first-page":"13473","DOI":"10.1074\/jbc.M900075200","volume":"284","author":"BR Thompson","year":"2009","unstructured":"Thompson BR, Mazurkiewicz-Munoz AM, Suttles J, Carter-Su C, Bernlohr DA (2009) Interaction of adipocyte fatty acid-binding protein (AFABP) and JAK2: AFABP\/aP2 as a regulator of JAK2 signaling. J Biol Chem 284:13473\u201313480","journal-title":"J Biol Chem"},{"issue":"Suppl","key":"3602_CR28","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1194\/jlr.R800079-JLR200","volume":"50","author":"SJ Wakil","year":"2009","unstructured":"Wakil SJ, Abu-Elheiga LA (2009) Fatty acid metabolism: target for metabolic syndrome. J Lipid Res 50(Suppl):S138\u2013S143","journal-title":"J Lipid Res"},{"key":"3602_CR29","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.1123965","volume":"312","author":"G Haemmerle","year":"2006","unstructured":"Haemmerle G, Lass A, Zimmermann R, Gorkiewicz G, Meyer C, Rozman J, Heldmaier G, Maier R, Theussl C, Eder S, Kratky D (2006) Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 312:734\u2013737","journal-title":"Science"},{"key":"3602_CR30","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1073\/pnas.97.2.787","volume":"97","author":"JI Osuga","year":"2000","unstructured":"Osuga JI, Ishibashi S, Oka T, Yagyu H, Tozawa R, Fujimoto A, Shionoiri F, Yahagi N, Kraemer FB, Tsutsumi O, Yamada N (2000) Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proc Natl Acad Sci USA 97:787\u2013792","journal-title":"Proc Natl Acad Sci USA"},{"key":"3602_CR31","doi-asserted-by":"crossref","first-page":"15084","DOI":"10.1074\/jbc.M310985200","volume":"279","author":"M Sekiya","year":"2004","unstructured":"Sekiya M, Osuga J, Okazaki H, Yahagi N, Harada K, Shen WJ, Tamura Y, Tomita S, Iizuka Y, Ohashi K, Okazaki M, Sata M, Nagai R, Fujita T, Shimano H, Kraemer FB, Yamada N, Ishibashi S (2004) Absence of hormone-sensitive lipase inhibits obesity and adipogenesis in Lep ob\/ob mice. J Biol Chem 279:15084\u201315090","journal-title":"J Biol Chem"},{"key":"3602_CR32","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1210\/en.2015-1322","volume":"156","author":"G Schoiswohl","year":"2015","unstructured":"Schoiswohl G, Stefanovic-Racic M, Menke MN, Wills RC, Surlow BA, Basantani MK, Sitnick MT, Cai L, Yazbeck CF, Stolz DB, Pulinilkunnil T, O\u2019Doherty RM, Kershaw EE (2015) Impact of reduced ATGL-mediated adipocyte lipolysis on obesity-associated insulin resistance and inflammation in male mice. Endocrinology 156:3610\u20133624","journal-title":"Endocrinology"},{"key":"3602_CR33","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jnutbio.2010.03.005","volume":"22","author":"F Bertile","year":"2011","unstructured":"Bertile F, Raclot T (2011) ATGL and HSL are not coordinately regulated in response to fuel partitioning in fasted rats. J Nutr Biochem 22:372\u2013379","journal-title":"J Nutr Biochem"},{"key":"3602_CR34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cyto.2008.10.006","volume":"45","author":"L Li","year":"2009","unstructured":"Li L, Yang G, Shi S, Yang M, Liu H, Boden G (2009) The adipose triglyceride lipase, adiponectin and visfatin are downregulated by tumor necrosis factor-alpha (TNF-alpha) in vivo. Cytokine 45:12\u201319","journal-title":"Cytokine"},{"key":"3602_CR35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1152\/physrev.00003.2009","volume":"90","author":"JF Glatz","year":"2010","unstructured":"Glatz JF, Luiken JJ, Bonen A (2010) Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease. Physiol Rev 90:367\u2013417","journal-title":"Physiol Rev"},{"key":"3602_CR36","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/1050-1738(95)00102-6","volume":"5","author":"JE Schaffer","year":"1995","unstructured":"Schaffer JE, Lodish HF (1995) Molecular mechanism of long-chain fatty acid uptake. Trends Cardiovasc Med 5:218\u2013224","journal-title":"Trends Cardiovasc Med"},{"key":"3602_CR37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/MOL.0b013e3281338558","volume":"18","author":"RE Gimeno","year":"2007","unstructured":"Gimeno RE (2007) Fatty acid transport proteins. Curr Opin Lipidol 18:271\u2013276","journal-title":"Curr Opin Lipidol"},{"key":"3602_CR38","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/sj.bjp.0707563","volume":"153","author":"C Alfarano","year":"2008","unstructured":"Alfarano C, Sartiani L, Nediani C, Mannucci E, Mugelli A, Cerbai E, Raimondi L (2008) Functional coupling of angiotensin II type 1 receptor with insulin resistance of energy substrate uptakes in immortalized cardiomyocytes (HL-1 cells). Br J Pharmacol 153:907\u2013914","journal-title":"Br J Pharmacol"},{"key":"3602_CR39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.phrs.2012.02.010","volume":"66","author":"K Taguchi","year":"2012","unstructured":"Taguchi K, Matsumoto T, Kamata K, Kobayashi T (2012) Angiotensin II type 2 receptor-dependent increase in nitric oxide synthase activity in the endothelium of db\/db mice is mediated via a MEK pathway. Pharmacol Res 66:41\u201350","journal-title":"Pharmacol Res"},{"key":"3602_CR40","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s00125-011-2114-8","volume":"54","author":"GP Holloway","year":"2011","unstructured":"Holloway GP, Chou CJ, Lally J, Stellingwerff T, Maher AC, Gavrilova O, Haluzik M, Alkhateeb H, Reitman ML, Bonen A (2011) Increasing skeletal muscle fatty acid transport protein 1 (FATP1) targets fatty acids to oxidation and does not predispose mice to diet-induced insulin resistance. Diabetologia 54:1457\u20131467","journal-title":"Diabetologia"},{"key":"3602_CR41","doi-asserted-by":"crossref","first-page":"e0167704","DOI":"10.1371\/journal.pone.0167704","volume":"11","author":"K Tsukuda","year":"2016","unstructured":"Tsukuda K, Mogi M, Iwanami J, Kanno H, Nakaoka H, Wang XL, Bai HY, Shan BS, Kukida M, Higaki A, Yamauchi T, Min LJ, Horiuchi M (2016) Enhancement of adipocyte browning by angiotensin II type 1 receptor blockade. PLoS ONE 11:e0167704","journal-title":"PLoS ONE"},{"key":"3602_CR42","doi-asserted-by":"crossref","first-page":"e13824","DOI":"10.14814\/phy2.13824","volume":"6","author":"DT Quiroga","year":"2018","unstructured":"Quiroga DT, Munoz MC, Gil C, Pffeifer M, Toblli JE, Steckelings UM, Giani JF, Dominici FP (2018) Chronic administration of the angiotensin type 2 receptor agonist C21 improves insulin sensitivity in C57BL\/6 mice. Physiol Rep 6:e13824","journal-title":"Physiol Rep"},{"key":"3602_CR43","doi-asserted-by":"crossref","first-page":"e17022","DOI":"10.1038\/sigtrans.2017.22","volume":"2","author":"A Than","year":"2017","unstructured":"Than A, Xu S, Li R, Leow M-S, Sun L, Chen P (2017) Angiotensin type 2 receptor activation promotes browning of white adipose tissue and brown adipogenesis. Signal Transduct Target Ther 2:e17022","journal-title":"Signal Transduct Target Ther"},{"key":"3602_CR44","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1093\/eurheartj\/ehn387","volume":"29","author":"GR Hajer","year":"2008","unstructured":"Hajer GR, van Haeften TW, Visseren FL (2008) Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 29:2959\u20132971","journal-title":"Eur Heart J"},{"key":"3602_CR45","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrm2391","volume":"9","author":"A Guilherme","year":"2008","unstructured":"Guilherme A, Virbasius JV, Puri V, Czech MP (2008) Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9:367\u2013377","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3602_CR46","doi-asserted-by":"crossref","first-page":"E999","DOI":"10.1152\/ajpendo.00377.2009","volume":"297","author":"B Gustafson","year":"2009","unstructured":"Gustafson B, Gogg S, Hedjazifar S, Jenndahl L, Hammarstedt A, Smith U (2009) Inflammation and impaired adipogenesis in hypertrophic obesity in man. Am J Physiol Endocrinol Metabol 297:E999\u2013E1003","journal-title":"Am J Physiol Endocrinol Metabol"},{"key":"3602_CR47","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1097\/01.hjh.0000174077.88121.19","volume":"23","author":"J Ran","year":"2005","unstructured":"Ran J, Hirano T, Adachi M (2005) Angiotensin II infusion increases hepatic triglyceride production via its type 2 receptor in rats. J Hypertens 23:1525\u20131530","journal-title":"J Hypertens"},{"key":"3602_CR48","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.celrep.2016.07.003","volume":"16","author":"NK Littlejohn","year":"2016","unstructured":"Littlejohn NK, Keen HL, Weidemann BJ, Claflin KE, Tobin KV, Markan KR, Park S, Naber MC, Gourronc FA, Pearson NA, Liu X, Morgan DA, Klingelhutz AJ, Potthoff MJ, Rahmouni K, Sigmund CD, Grobe JL (2016) Suppression of resting metabolism by the angiotensin AT2 receptor. Cell Rep 16:1548\u20131560","journal-title":"Cell Rep"},{"key":"3602_CR49","doi-asserted-by":"crossref","first-page":"F700","DOI":"10.1152\/ajprenal.00616.2010","volume":"300","author":"R Sabuhi","year":"2011","unstructured":"Sabuhi R, Ali Q, Asghar M, Al-Zamily NR, Hussain T (2011) Role of the angiotensin II AT2 receptor in inflammation and oxidative stress: opposing effects in lean and obese Zucker rats. Am J Physiol Renal Physiol 300:F700\u2013F706","journal-title":"Am J Physiol Renal Physiol"},{"key":"3602_CR50","doi-asserted-by":"crossref","first-page":"e48387","DOI":"10.1371\/journal.pone.0048387","volume":"7","author":"K Ohshima","year":"2012","unstructured":"Ohshima K, Mogi M, Jing F, Iwanami J, Tsukuda K, Min LJ, Ogimoto A, Dahlof B, Steckelings UM, Unger T, Higaki J, Horiuchi M (2012) Direct angiotensin II type 2 receptor stimulation ameliorates insulin resistance in type 2 diabetes mice with PPARgamma activation. PLoS ONE 7:e48387","journal-title":"PLoS ONE"},{"key":"3602_CR51","doi-asserted-by":"crossref","first-page":"E197","DOI":"10.1152\/ajpendo.00149.2012","volume":"304","author":"M Shum","year":"2013","unstructured":"Shum M, Pinard S, Guimond MO, Labbe SM, Roberge C, Baillargeon JP, Langlois MF, Alterman M, Wallinder C, Hallberg A, Carpentier AC, Gallo-Payet N (2013) Angiotensin II type 2 receptor promotes adipocyte differentiation and restores adipocyte size in high-fat\/high-fructose diet-induced insulin resistance in rats. Am J Physiol Endocrinol Metabol 304:E197\u2013E210","journal-title":"Am J Physiol Endocrinol Metabol"},{"key":"3602_CR52","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/HYPERTENSIONAHA.111.00422","volume":"61","author":"I Dhande","year":"2013","unstructured":"Dhande I, Ali Q, Hussain T (2013) Proximal tubule angiotensin AT2 receptors mediate an anti-inflammatory response via interleukin-10: role in renoprotection in obese rats. Hypertens 61:1218\u20131226","journal-title":"Hypertens"},{"key":"3602_CR53","doi-asserted-by":"crossref","first-page":"F1379","DOI":"10.1152\/ajprenal.00002.2015","volume":"308","author":"Q Ali","year":"2015","unstructured":"Ali Q, Patel S, Hussain T (2015) Angiotensin AT2 receptor agonist prevents salt-sensitive hypertension in obese Zucker rats. Am J Physiol Renal Physiol 308:F1379\u2013F1385","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-019-03602-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-019-03602-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-019-03602-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T23:33:57Z","timestamp":1597275237000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-019-03602-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,14]]},"references-count":53,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["3602"],"URL":"https:\/\/doi.org\/10.1007\/s11010-019-03602-y","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,14]]},"assertion":[{"value":"8 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}